When he realized he wasn’t going to make it as a guitarist, Hiroaki Suga set out to find the origin of life, and ended up creating a new way to develop medicines.
Many years spent fiddling with the building blocks of the universe -- combining molecules to form compounds -- led to Suga developing an enzyme that opened the door to a faster method of discovering drugs. PeptiDream Inc., the company he co-founded, has inked deals with many of the world’s biggest pharma firms, and shares have surged more than ninefold since listing in 2013.
